145 related articles for article (PubMed ID: 11726138)
1. A stable single-chain variable fragment expressing transfectoma demonstrates induction of idiotype-specific cytotoxic T-cells during early growth stages of a murine B-lymphoma.
Laxmanan S; Stuart GW; Ghosh SK
Cancer Immunol Immunother; 2001 Oct; 50(8):437-44. PubMed ID: 11726138
[TBL] [Abstract][Full Text] [Related]
2. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. III. MHC class I-restricted CTL recognizes the processed form(s) of idiotype.
Chakrabarti D; Ghosh SK
Cell Immunol; 1992 Oct; 144(2):455-64. PubMed ID: 1394454
[TBL] [Abstract][Full Text] [Related]
3. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. II. Characterization of anti-idiotypic CTL lines and clones.
Chakrabarti D; Ghosh SK
Cell Immunol; 1992 Oct; 144(2):443-54. PubMed ID: 1394453
[TBL] [Abstract][Full Text] [Related]
4. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. I. Role of idiotypic immunoglobulin.
Chakrabarti D; Ghosh SK
Cell Immunol; 1992 Jun; 142(1):54-66. PubMed ID: 1586959
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation by processed immunoglobulin on B-cells.
Ghosh SK; Chakrabarti D
Indian J Biochem Biophys; 1993 Dec; 30(6):414-21. PubMed ID: 7911781
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
[TBL] [Abstract][Full Text] [Related]
7. Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine.
Lim SY; Laxmanan S; Stuart G; Ghosh SK
Cancer Detect Prev; 2001; 25(5):470-8. PubMed ID: 11718453
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 is effective in restoring cytotoxic T cell activity that declines during in vivo progression of a murine B lymphoma.
Santra S; Ghosh SK
Cancer Immunol Immunother; 1997 Jul; 44(5):291-300. PubMed ID: 9247564
[TBL] [Abstract][Full Text] [Related]
9. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Blood; 2002 Nov; 100(9):3155-63. PubMed ID: 12384413
[TBL] [Abstract][Full Text] [Related]
10. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies.
Cesco-Gaspere M; Benvenuti F; Burrone OR
Cancer Immunol Immunother; 2005 Apr; 54(4):351-8. PubMed ID: 15692846
[TBL] [Abstract][Full Text] [Related]
11. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
12. A genetic approach to idiotypic vaccination for B cell lymphoma.
Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
[TBL] [Abstract][Full Text] [Related]
13. GD2 oligosaccharide: target for cytotoxic T lymphocytes.
Zhao XJ; Cheung NK
J Exp Med; 1995 Jul; 182(1):67-74. PubMed ID: 7540657
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth.
BenAmmar-Ceccoli S; Humblot S; Crouzier R; Acres B; Kieny MP; Herlyn D; Pasquali JL; Martin T
Cancer Gene Ther; 2001 Oct; 8(10):815-26. PubMed ID: 11687905
[TBL] [Abstract][Full Text] [Related]
15. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
Kawahara DJ; Marrack P; Kappler JW
J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
[TBL] [Abstract][Full Text] [Related]
16. Idiotype-specific T lymphocytes. I. Regulation of antibody production by idiotype-specific H-2-restricted T lymphocytes.
Yamamoto H; Bitoh S; Torii M; Fujimoto S
J Immunol; 1983 Mar; 130(3):1038-42. PubMed ID: 6185567
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
Billetta R; Filaci G; Zanetti M
Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae.
Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M
Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286
[TBL] [Abstract][Full Text] [Related]
20. Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells.
Lim SY; Ghosh SK
Immunology; 2004 May; 112(1):94-104. PubMed ID: 15096189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
